DRUG INDICATION ACTIONSIDE EFFECTS ANDADVERSE REACTIONNURSINGCONSIDERATIONPATIENT TEACHINGGeneric Name:
IV (-) ANST
June 28, 2011Short-termmanagement of pain up to 5days
It inhibitsprostaglandinsynthesis byblocking COX-1(Cyclooxygenase-1) which results tothe reduction of pain perceived bythe client(analgesic) andreduction of signsof inflammation(anti-inflammatory).
: headache, dizziness,drowsiness, fatigue
diarrhea, nausea,vomiting, flatulence,dyspepsia, constipation
gastric or duodenalulcer, dark tarry stool,hematemesis (brightred/coffee ground emesis),hepatotoxicity
bonemarrow depression(decreased WBC,decreased platelets,decreased Hct)
Pain, abcess atinjection site, phlebitis,inflammation at IV site
Impairedhearing, allergies,renal impairment;hepatic, CV, and GIconditions
skin colorand lesions,orientation, reflexes,opthalmologic andaudiometricevaluation,adventitious sounds,liver evaluation,CBC, renal functiontests, serum test
Avoid activities thatrequire alertness untilresponse to medication isknown.
Advise patient tominimize GI upset byeating small, frequentservings of healthy foods.
Instruct patient to avoidaspirin products and herbsduring therapy.
Instruct patient to reportimmediately to healthcareprovider if he/sheexperience any side oradverse effects.